Skip to content

Baseline medication use is associated with Covid-19 severity in people with rheumatic diseases

Priscilla Lynch provides a round-up of some of the most topical research presented at this year’s EULAR Congress, which took place virtually from 2-5 June Two abstracts presented at EULAR 2021 show people taking rituximab or Janus kinase inhibitors (JAKi) have worse Covid-19 severity compared to people taking tumour necrosis factor inhibitors (TNFi). These data…

Read More

Decline in excess risk of dementia and heart failure in patients with rheumatoid arthritis

Priscilla Lynch provides a round-up of some of the most topical research presented at this year’s EULAR Congress, which took place virtually from 2-5 June Data released at the 2021 EULAR Congress show a substantial decline in the risk of both dementia and heart failure in people with RA onset in the 2000s as compared…

Read More

Pregnancy outcomes are affected by both maternal and paternal inflammatory disease

Priscilla Lynch provides a round-up of some of the most topical research presented at this year’s EULAR Congress, which took place virtually from 2-5 June Data presented at the 2021 EULAR Congress show women with rheumatoid arthritis (RA) are at increased risks of adverse pregnancy outcomes, especially pre-term birth (PTB) and babies small for gestational…

Read More

Treatment with tumour necrosis factor inhibitors may slow disease progression in patients with axSpA

Priscilla Lynch provides a round-up of some of the most topical research presented at this year’s EULAR Congress, which took place virtually from 2-5 June Sacroiliitis is linked to the disease axial spondyloarthritis (axSpA) and visible on X-ray. Observational cohort studies have shown that there is low, but still detectable progression in radiographic sacroiliitis, which…

Read More

Passive smoking and air pollution – links to arthritis development and poor response to therapy

Priscilla Lynch provides a round-up of some of the most topical research presented at this year’s EULAR Congress, which took place virtually from 2-5 June New data shared at the 2021 EULAR Congress highlighted the increasing evidence that environmental air pollution is associated with people developing inflammatory arthritis. A large population-based study of French women…

Read More

New data on Covid-19 morbidity and mortality in people with rheumatic diseases

Priscilla Lynch provides a round-up of some of the most topical research presented at this year’s EULAR Congress, which took place virtually from 2-5 June Population-based data from Spain presented at the 2021 EULAR Congress show individuals with rheumatoid arthritis (RA) had an increased risk of Covid-19 diagnosis and hospitalisation compared to the general population.…

Read More

EULAR Congress 2021

Priscilla Lynch provides a round-up of some of the most topical research presented at this year’s EULAR Congress, which took place virtually from 2-5 June Older patients not at increased risk of serious infections with new disease-modifying antirheumatic drugs compared to conventional synthetic treatments The results of a new study presented at the 2021 EULAR…

Read More

Optimum management of rheumatoid arthritis – a case study

About 1 per cent of the population have RA, with three million people living with RA in Europe, and about 45,000 people in Ireland Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune condition with periods of exacerbation and remission, characterised by synovitis and joint destruction mediated by cytokines, chemokines, and metalloproteases.RA can affect any…

Read More

Lung cancer screening: Is Ireland ready?

In Ireland, lung cancer remains the most common cause of cancer-related deaths and accounts for more deaths per year than breast and prostate cancers combined Lung cancer remains the most common cause of cancer-related death in Ireland. During the period 2015-2017, there was an average of 1,884 deaths per year with 20 per cent of…

Read More

ASCO 2021 round-up

Priscilla Lynch presents a round-up of some of the most topical research presented at this year’s ASCO Annual Meeting ASCO rapid guideline update for HER2-negative breast cancer Anew American Society of Clinical Oncology (ASCO) guideline update recommends offering one year of adjuvant olaparib to patients with high-risk early-stage human epidermal growth factor receptor 2 (HER2)-negative…

Read More
Scroll To Top